Rafarma Pharmaceuticals, Inc.
OTC: RAFA0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Sergey Brusnitsin
- Employees
- 700
- Headquarters
- Sandy, United States
- IPO year
- 2012
- Market cap
- $3.5M
- Website
- https://rafarma.si
Loading RAFA…
Loading profile data…Frequently asked questions about RAFA
What does Rafarma Pharmaceuticals, Inc. (RAFA) do?
Rafarma Pharmaceuticals, Inc. is a diversified pharmaceutical enterprise that manufactures and distributes a range of medicinal products, including generic antibiotics and specialized drugs, within the Russian market. Its product portfolio encompasses anti-cancer medications, cephalosporin-derived compounds, and non-beta-lactam antibiotics. Thes...
Where does RAFA trade?
Rafarma Pharmaceuticals, Inc. (RAFA) trades on the Other OTC.
What sector is RAFA in?
Rafarma Pharmaceuticals, Inc. (RAFA) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Rafarma Pharmaceuticals, Inc.?
Sergey Brusnitsin is the chief executive officer of Rafarma Pharmaceuticals, Inc. (RAFA).
Where is Rafarma Pharmaceuticals, Inc. headquartered?
Rafarma Pharmaceuticals, Inc. is headquartered in United States.
Does RAFA pay a dividend?
Rafarma Pharmaceuticals, Inc. (RAFA) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did RAFA go public?
Rafarma Pharmaceuticals, Inc. (RAFA) completed its initial public offering in 2012.